Skip to main content
VCbacked
Log inGet Started

Shinobi Therapeutics

South San Francisco, United States

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

$68.0M raised
Aug 2024
Series A
BiotechnologyHealth CareTherapeutics

Top Investors

Mitsubishi UFJ CapitalEQT Life SciencesJIC Venture Growth InvestmentsF-Prime CapitalYosemite

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Shinobi Therapeutics

How much funding has Shinobi Therapeutics raised?
Shinobi Therapeutics has raised $68.0M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
Who are Shinobi Therapeutics's investors?
Shinobi Therapeutics's investors include Mitsubishi UFJ Capital, EQT Life Sciences, JIC Venture Growth Investments, F-Prime Capital, Yosemite.
Where is Shinobi Therapeutics headquartered?
Shinobi Therapeutics is headquartered in South San Francisco, United States.
What does Shinobi Therapeutics do?
Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.
What stage is Shinobi Therapeutics at?
Shinobi Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Shinobi Therapeutics — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/shinobi-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Shinobi Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/shinobi-therapeutics
Wikipedia (cite web)
{{cite web |title=Shinobi Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/shinobi-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong